|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.87 USD | +0.12% |
|
-1.47% | +25.03% |
| Capitalization | 128B 109B 102B 95.86B 176B 11,597B 193B 1,189B 461B 5,466B 480B 470B 19,944B | P/E ratio 2026 * |
23x | P/E ratio 2027 * | 21.1x |
|---|---|---|---|---|---|
| Enterprise value | 151B 129B 120B 113B 208B 13,674B 227B 1,402B 544B 6,446B 566B 555B 23,516B | EV / Sales 2026 * |
4.19x | EV / Sales 2027 * | 3.9x |
| Free-Float |
99.72% | Yield 2026 * |
2.84% | Yield 2027 * | 2.97% |
Last Transcript: Medtronic plc
| 1 day | +0.12% | ||
| 1 week | -1.47% | ||
| Current month | -5.18% | ||
| 1 month | +3.88% | ||
| 3 months | +6.21% | ||
| 6 months | +14.44% | ||
| Current year | +25.03% |
| 1 week | 99 | 102.49 | |
| 1 month | 95.8 | 106.33 | |
| Current year | 79.55 | 106.33 | |
| 1 year | 79.29 | 106.33 | |
| 3 years | 68.84 | 106.33 | |
| 5 years | 68.84 | 135.89 | |
| 10 years | 68.84 | 135.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 55 | 2020-04-26 |
Thierry Pieton
DFI | Director of Finance/CFO | 55 | 2025-03-02 |
Laura Mauri
CTO | Chief Tech/Sci/R&D Officer | - | 2020-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Arnold
BRD | Director/Board Member | 65 | 2015-01-25 |
Scott Donnelly
BRD | Director/Board Member | 63 | 2012-12-31 |
Randall Hogan
BRD | Director/Board Member | 69 | 2014-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.12% | -1.47% | +21.08% | +24.62% | 128B | ||
| +1.77% | +0.30% | +10.65% | +12.49% | 218B | ||
| +0.44% | +1.87% | +48.98% | +109.66% | 67.12B | ||
| +0.23% | +3.57% | -10.94% | -20.93% | 57.34B | ||
| +1.79% | -0.02% | +18.70% | +72.96% | 51.86B | ||
| -2.87% | +2.24% | -13.25% | -43.99% | 26.12B | ||
| -0.28% | -4.36% | +17.54% | +26.48% | 24.71B | ||
| -1.06% | -3.80% | +5.72% | -37.11% | 23.44B | ||
| +0.63% | -2.38% | -24.21% | +16.21% | 21.9B | ||
| +0.52% | -2.89% | +9.79% | -5.53% | 20.8B | ||
| Average | +0.13% | -0.69% | +8.41% | +15.49% | 63.95B | |
| Weighted average by Cap. | +0.71% | -0.07% | +13.37% | +22.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.06B 30.72B 28.69B 27B 49.71B 3,266B 54.3B 335B 130B 1,540B 135B 132B 5,617B | 38.16B 32.51B 30.37B 28.57B 52.6B 3,456B 57.47B 354B 137B 1,629B 143B 140B 5,944B |
| Net income | 5.39B 4.6B 4.29B 4.04B 7.44B 489B 8.12B 50.11B 19.44B 230B 20.24B 19.81B 840B | 6.04B 5.15B 4.81B 4.52B 8.33B 547B 9.1B 56.1B 21.76B 258B 22.66B 22.19B 941B |
| Net Debt | 22.93B 19.54B 18.25B 17.17B 31.61B 2,077B 34.54B 213B 82.63B 979B 86.05B 84.24B 3,572B | 20.95B 17.85B 16.67B 15.68B 28.87B 1,897B 31.54B 195B 75.47B 894B 78.6B 76.94B 3,263B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 99.87 $ | +0.12% | 6,546,521 |
| 25-12-11 | 99.75 $ | -1.01% | 8,339,069 |
| 25-12-10 | 100.77 $ | +1.15% | 6,158,778 |
| 25-12-09 | 99.62 $ | -1.62% | 4,666,268 |
| 25-12-08 | 101.26 $ | -0.10% | 5,528,785 |
Delayed Quote Nyse, December 12, 2025 at 04:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MDT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















